GlaxoSmithKline bolstered its cancer drug development pipeline, agreeing to pay up to 3.7 billion euros ($4.22 billion) to Germany's Merck KGaA for the rights to a novel immunotherapy.
The European Union's top health official hit out at Greece's deputy health minister for publicly defying the country's smoking ban, saying in remarks published on Tuesday the practice was shameful.
Swiss drugmaker Roche aims to broaden the use of its Kadcyla breast cancer treatment as rivals crowd into the market with biosimilar copies of its older mainstay Herceptin.
Johnson & Johnson's DePuy Orthopaedics unit is in settlement talks to resolve the bulk of individual lawsuits alleging the company's metal-on-metal Pinnacle hip implants were defective and caused severe injuries, a lawyer for the plaintiffs said on Monday.
A powerful U.S. Senate committee on Monday invited seven pharmaceutical companies to testify at a hearing later this month examining rising prescription drug prices.
(Reuters Health) - Compounded pain creams are no better for chronic pain than topical treatments that contain no medicine at all, a U.S. study suggests.
U.S. Senator Bernie Sanders sent a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free.
(Reuters Health) - Drivers who don't wear seatbelts are more likely to skip seatbelts and car seats for their kids, an analysis of U.S. crash data suggests.
(Reuters Health) - Cancer patients are more successful at giving up cigarettes for good if they take smoking-cessation medicine for 24 weeks instead of the usual 12 weeks, a small clinical trial suggests.
(Reuters Health) - Just one in 20 U.S. children and teens gets the amount of sleep, exercise and screen time that doctors recommend for optimal health, a new study suggests.
Related Videos
Introducing the all-new Reuters News app
The new Reuters News app is here, redesigned from the ground up to fit your busy life.
